Articles On Polynovo (ASX:PNV)

ASX biotech shares have been persistent outperformers in recent times. CSL Limited (ASX: CSL) is one of the largest ASX shares by market capitalisation with a $127.6 billion valuation based on the current CSL share price. However, CSL shar...

It’s hard to know where to invest $10,000 in ASX shares right now. I like to keep a long-term perspective to drown out the market noise. Here are a few of my favourite listed companies that I’d love to buy with some spare cash today. Where...

Now is a great time for beginners to start buying ASX shares. Yes, the market is volatile and the coronavirus pandemic has caused a lot of uncertainty. However, that also presents a buying opportunity. On top of that, the August earnings s...

Are you interested in adding some growth shares to your portfolio? Then I think the three named below could be great options. I feel all three are well-positioned to deliver above-average earnings growth over the next few years, which coul...

There are few ASX shares that I would buy today in this current climate. We are living in uncertain times with COVID-19 causing disruptions and impacting businesses across the globe. Yet despite this, valuations on some companies have soar...

Like all financial markets, ASX shares produce winners and losers. Some companies soar to spectacular market capitalisations as their product or service takes off. Others see share prices deteriorate as markets and demand shift. When inv...

It seems investors in these two ASX medical shares have taken the opportunity to lock in recent gains, sending prices down significantly in July. The Avita Therapeutics Inc (ASX: AVH) share price fell more than 30% in July as sales faltere...

I think the healthcare sector is a great place to invest with a long term view due to the favourable tailwinds that it is experiencing. These include ageing populations around the globe, increased chronic disease burden, and better technol...

As the economic outlook grows increasingly gloomy, many investors may be thinking of diversifying into defensive companies as a way of strengthening their portfolios. Generally, healthcare companies provide a good defence against a downtur...

Long-term shareholders of emerging ASX healthcare company Opthea Ltd (ASX: OPT) have endured a volatile 12 months. A little under a year ago, the Opthea share price was trading at a 52-week low of just $0.735. Then, in the space of a month...

The Polynovo Ltd (ASX: PNV) share price could be set to push higher in 2020. Here’s why I see some tailwinds behind the Aussie biotech ahead of its August earnings result. How has the Polynovo share price performed recently? The Polynovo s...

Like many companies, junior ASX healthcare company Medical Developments International Limited (ASX: MVP) has had a volatile 2020. After soaring to an all-time high of $11.78 in February, the Medical Developments share price was savaged in...

It’s been a great day for Australian shares today, with the S&P/ASX 200 Index (ASX: XJO) up by 2.3% at the time of  writing. In particular, the biotech sector and the tech sector have been standout performers. Here we examine 4 ASX bio...

Growth and dividends. That’s the holy grail that most ASX 200 share investors are looking for. It’s a rare combination, but one that can be an absolute gold mine if you can find it. If you’re looking to invest $10,000 for both growth and d...

The medical device industry includes any device which can diagnose, prevent, or treat a disease or other condition. Examples range from bandages and syringes to pacemakers and prostheses. These technologies save and improve lives by detect...

Shares in Melbourne-based medtech company Polynovo Ltd [ASX:PNV] have slid for a fifth consecutive day. Today’s dip in the PNV share price comes on the back of new funding for clinical trials of its proprietary NovoSorb regeneration solutio...

If you’re looking for growth shares to buy then I think the healthcare sector is a great place to start. This is because thanks to new technologies and favourable tailwinds, demand for healthcare services looks set to grow strongly over th...

A month away from hitting the ASX, 4DMedical has its sights set on the United States and its spiralling COVID-19 situation as a target market for its lung imaging technology. The Australian medtech is developing a patented X-ray imaging pla...

This year has been a bit of a mixed bag for ASX healthcare companies. Many have seen their share prices surge higher as investors sought out the safety of defensive shares in the face of extreme economic uncertainty. The share price of res...

Looking to add some growth shares to your portfolio next week? Listed below are three fast-growing companies that I think could be worth considering. Here’s why I think these ASX growth shares could be top long term investment options: Br...

The S&P/ASX 200 Index (ASX: XJO) fell by 0.6% today to 5,919 points. The alarming COVID-19 spread continues in Melbourne with Victoria reporting 288 new cases today. However, two new infections in NSW that seemingly came from a Sydney...

The PolyNovo Ltd (ASX: PNV) share price is pushing higher in morning trade following the release of a trading update. At the time of writing the medical device company’s shares are up 2% to $2.49. What did PolyNovo announce? PolyNovo has b...

PolyNovo (ASX: PNV) shares are on watch this morning after releasing an FY20 trading update. What is PolyNovo? PolyNovo is an Australian medical device company that designs, develops, and manufactures dermal regeneration solutions using its...

I continue to believe that the mid cap space is a great place to look for long term investment ideas. This is because I feel there are a number of mid cap shares that have the potential to grow into large caps in the future, potentially ge...

Australia is an amazingly innovative country – from the medical application of penicillin, the invention of WiFi, right through to the cochlear implant or bionic ear. Heck, Australia was even the birthing ground for what would become Googl...

The Polynovo Ltd (ASX: PNV) share price was a strong performer last week and closed the five days of trade 8.1% higher at $2.66 per share. At the time of writing on Monday, Polynovo shares had edged slightly lower to $2.64. Shares in the A...

If you’re interested in adding some growth shares to your portfolio, then I think the three named below could be great options. I believe all three are well-positioned to deliver above-average earnings growth over the next few years and co...

It’s fair to say that investors in Polynovo Ltd (ASX: PNV) and JB Hi-Fi Limited (ASX: JBH) shares enjoyed a bumper last 12 months. For the financial year ending 30 June 2020 (FY20), both Polynovo and JB Hi-Fi shares rocketed around 63.9% h...

ShareCafeBest & Worst Performers On The ASX In FY 2019-20 There was the usual end of month, quarter, half-year and financial year window – dressing, tax selling and no doubt actual long term buying on the ASX yesterday. The last session...

Over the past 12 months, the S&P/ASX 200 (INDEXASX: XJO) is down 11%. But some ASX shares have bucked the trend and recorded major gains. We take a look at the top 10 performers over the past year.  Afterpay Ltd (ASX: APT) The Afterpay...

The S&P/ASX 200 Index (INDEXASX: XJO) fell by 1.5% yesterday, dragged down by most of the market. However, there was a number of shares that were able to defy the index and rose significantly. I think this is a good indicator of things...

If you’re a growth investor on the lookout for some new additions in July, then you might want to consider the three ASX shares listed below. I believe all three have the potential to generate strong returns for investors in the future. He...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is following the lead of U.S. markets and tumbling notably lower. At the time of writing the benchmark index is down 1.35% to 5,824.3 points. Four shares that have not let that hol...

The A2 Milk Company Ltd (ASX: A2M) share price has had an impressive run in the last 5 years. Shares in the Kiwi dairy group have rocketed 2,710.8% over that time to $18.27 per share. That means $10,000 invested 5 years ago would be worth...

With interest rates at ultra-low levels and looking likely to remain that way for the foreseeable future, I continue to believe investors would be better off putting any excess funds into the share market. But where should you invest these...

At lunch on Thursday the S&P/ASX 200 Index (ASX: XJO) looks set to end its positive run with a sizeable decline. The benchmark index is down 1.8% to 5,858.9 points. Here’s what has been happening on the market today: Qantas announces $...

Buying and holding ASX 200 shares can be a powerful way to build wealth and retire early. If equities are to form a crucial part of your retirement plans, obviously selecting the right shares to buy today is extremely important. For exampl...

The PolyNovo Ltd (ASX: PNV) share price may have jumped 56% over the last 12 months, but one fund manager believes it can still go higher. Who is bullish on PolyNovo? According to a recent update by the DNR Capital Australian Emerging Comp...

Michael Gable is an expert guest commentator for the Finance News Network, presenting “Stock Watch” each week – covering stock tips and shares on the Australian market (ASX). This video is dated 22 June 2020.  Shares covered: S&P 500, (...

The S&P/ASX 200 Index (ASX: XJO) fell by 0.9% today to 5,937 points. Today’s economic news was supplied by the Australian Bureau of Statistics (ABS). The data organisation said that total employment decreased by 227,700 people to 12.15...

Xero Limited (ASX: XRO) shares have been performing strongly in recent years and it looks like the cloud-based accounting software company is one of the hottest ASX growth shares right now. Personally, I think the Aussie company has strong...

ASX 200 shares continue to bounce back strongly in June. However, we’ve seen a minor wobble this week as the S&P/ASX 200 Index (ASX: XJO) has fallen lower for 2 consecutive days, and is down almost 3% this morning. Despite this, things...

There are a couple of ASX 200 biotech shares that could be in the buy zone right now. The S&P/ASX 200 Index (ASX: XJO) is down -10.25% this year but many Aussie healthcare companies have surged in value. This is partly due to the natur...

Healthcare is not the favourite child it was at the start of the COVID-19 pandemic, but one index measuring the sector is still up on the wider market. Biotech Daily’s top 40 index is up 14 per cent over the last month, compared to 4 per ce...

The PolyNovo Ltd (ASX: PNV) share price has been one of the best performers on the S&P/ASX 200 Index (ASX: XJO) over the last 12 months. Since this time last year the medical device company’s shares have climbed a massive 120%. If we g...

On Wednesday the S&P/ASX 200 Index (ASX: XJO) fought hard but fell just short at the close. The benchmark index dropped 5 points to 5,775 points. Will the market be able to bounce back from this on Thursday? Here are five things to wat...

Around 12 months ago, we noted that Avita Medical (AVH) – which provides a novel approach to skin regeneration – was a business worth keeping tabs on.  Although its share price has felt the effects of the COVID-19 market sell-off, our posit...

Building a massive portfolio of ASX shares from scratch is no easy feat. Creating real wealth through the share market takes time, dedication and discipline. But it can be done, nonetheless. One thing I’ve learned over time is that sometim...

Many ASX growth shares have rocketed higher despite the bear market in 2020. The S&P/ASX 200 Index (ASX: XJO) has slumped 16.60% lower this year while many top tech and healthcare shares have surged. But with all the craziness in the s...

We’re almost 2 months on from the fastest bear market on record, which saw the S&P/ASX 200 Index (ASX: XJO) fall 36.53% from 7,162.50 points on 20 February to a low of just 4,546 on 23 March. In the time since, however, the market has...